Mainz Biomed N V
13F holders, Q2 2024 (June 30)9holders −3
1new positions
4sold out
$0.40avg. 13F price*
At the end of Q2 2024, 9 institutions reported holding Mainz Biomed N V in their 13F filings, down 3 from Q1 2024. 1 opened new positions and 4 sold out. The largest holders were Northern Trust Corp. ($12K), Vontobel Holding Ltd. ($10K) and Geode Capital Management, LLC ($6K).
- Company
- Mainz Biomed N V
- CUSIP
- N5436L101
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 4 | $26K |
All 13F filers, Q1 2024 → Q2 2024: 10,000 shares bought and 53,454 shares sold, net −43,454 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Northern Trust Corp. | 0.00% | No change | 29,934 | $12K |
| Vontobel Holding Ltd. | 0.00% | No change | 25,000 | $10K |
| Geode Capital Management, LLC | 0.00% | No change | 15,189 | $6K |
| XTX Topco Ltd | 0.00% | Reduce -60.5% | 11,358 | $5K |
| Greenwich Investment Management, Inc. | 0.00% | Reduce -9.4% | 10,859 | $4K |
| Wealth Quarterback LLC | 0.00% | New | 10,000 | $4K |
| Citigroup Inc. | 0.00% | No change | 673 | $270 |
| Morgan Stanley | 0.00% | Reduce -98.0% | 200 | $80 |
| Bank of America Corp. | 0.00% | No change | 100 | $40 |
"% of holder's portfolio" is MAINZ BIOMED N V's weight in each manager's 13F, not the share of Mainz Biomed N V the manager owns.